Despite known associations between visceral fat and cancer, measuring it with MRI is costly. In a new publication from the Song Lab, we introduce a clinically accessible formula to estimate visceral fat, revealing strong links to cancer risk beyond traditional metrics like BMI.

🌟 Exciting News from Our Lab! 🌟 We’re thrilled to share our latest collaborative research with the Segata Lab Segata Lab published in Nature Microbiology! Our study reveals a fascinating connection between coffee consumption and the abundance of the gut microorganism

Our latest publication in JAMA Oncology, done in collaboration with the University of Oslo's Department of Nutrition, sheds light on colorectal cancer screening. Our findings suggest that the rescreening interval after a negative colonoscopy could be extended beyond 10 years,

We're honored to be featured in the Harvard Gazette for our recent journal article on colorectal cancer screening. Mingyang Song Andy Chan Kai Wang Harvard Cancer Epi Harvard Epidemiology Harvard T.H. Chan School of Public Health Our findings have significant implications for personalized healthcare:

We’re excited to announce that 10 researchers from the Song Lab will present their work at Digestive Disease Week (DDW) 2025! Our efforts in GI research and cancer epidemiology focus on translating findings into future real-world impact. Key focus areas include: -The impact of

New Seminar Alert 🚨 Join us on Friday, March 21 at 2:00pm EST for Dr. Marc Gunter's presentation on "Metabolic Dysfunction and Cancer: New Insights from Molecular Epidemiology and Interventional Approaches" Attend in person or virtually. Register now ⬇️ harvard.az1.qualtrics.com/jfe/form/SV_9y…

Our lab is headed to sunny San Diego for #DDW2025 May 3–6! 🌴 We’re presenting exciting new research on GI cancer prevention, the microbiome, metabolomics, and more. Catch us on site or online at Digestive Disease Week! We’ll be sharing more details about our presentations in the weeks

🔬 Presentation Spotlight | #DDW2025 🔬 Song Lab member Xinyu Wang will be presenting in the GI Oncology Plenary session at Digestive Disease Week 2025 on May 4. She’ll share findings on how the metabolomic signature of ultra-processed food (UPF) intake was linked to a higher

This May, we are proud to feature Song Lab over the coming weeks 🎉 The Song Lab, founded in 2018 by Principal Investigator Mingyang Song, focuses on the clinical & translational epidemiology of #colorectalcancer Follow us to learn more about the lab all month long

Why is colorectal cancer risk still high after adenoma removal? The gut microbiome and its metabolites might hold the answer! Dive into our findings with Ana Nogal at #DDW2025. #Microbiome #CRC

Maintaining a healthy lifestyle after a colorectal cancer diagnosis is linked to a significantly lower risk of cardiovascular disease and mortality. These findings highlight the importance of integrating lifestyle interventions into oncology care to improve cardiovascular health

Yesterday, Markus Dines Knudsen and Song Lab PI Mingyang Song shared compelling findings on how adopting healthier lifestyle habits after a colonoscopy screening could lower the risk of colorectal cancer and other major chronic diseases. #DDW2025 Their research highlights the

Colorectal polyps are increasingly being found in adults under 50. This concerning trend may help explain the rising number of colorectal cancer cases in younger individuals. At this year's Digestive Disease Week (DDW), Song Lab visiting scholar Yufeng Chen presented research

Exciting news from the Throne Holst Symposium at the University of Oslo’s Department of Nutrition! 🎉 This year, Markus Dines Knudsen—nominated by Anette Hjartåker, research group leader of Nutritional Epidemiology—was awarded Best Article of the Year by a Young Scientist for

New Research on Traditional Serrated Adenomas and Colorectal Cancer Risk! 🌟 Excited to share important new findings from our team! Our lab member, Dr. Yufeng Chen, is first author on a newly published study in the American Journal of Gastroenterology that sheds light on the

Study in Progress: Investigating Coffee and Cancer Survivorship We are pleased to provide an update on our ongoing clinical research at Massachusetts General Hospital. The COMMENCER trial (COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER) is a